Impact of Prostate Volume on the Efficacy of High-Power Potassium-Titanyl-Phosphate Photoselective Vaporization of the Prostate: A Retrospective, Short-Term Follow-Up Study on Evaluating Feasibility and Safety

다국어 초록 (Multilingual Abstract)

Purpose: We determined the impact of prostate volume on the efficacy of the high-power (80 W) potassium-titanyl-phosphate (KTP) photoselective laser vaporization of the prostate in men with lower urinary tract symptoms (LUTS).
Materials and Methods: Patients were stratified into 3 groups according to prostate volume: ‘< 40 g’ (n = 49) and ‘40-59 g’ (n = 49) and ‘≥ 60 g’ (n = 22).
Median follow-up was 9 months (range 6 to 21). Results: No differences in age and follow-up duration were observed in the three groups. At baseline, no significant differences were noted in the three groups in terms of the International Prostate Symptom Score (IPSS) (21.4, 19.4 and 19.1; p = 0.412) as well as the maximum flow rate (Qmax) (10.2, 9.2, and 8.6 mL/s; p = 0.291) and post-void residual (PVR) (66.2, 80.4, and 71.5 mL; p = 0.856). The mean operative times were 30.9, 46.9, and 58.6 minutes (p < 0.001) and total median energy deliveries for each group were 62.3, 97.6, and 135.9 kJ, respectively (p < 0.001). No severe intraoperative complication was observed. At the last follow-up, these parameters improved significantly regardless of prostate volume, and the IPSS (11.1, 9.4, and 12.3; p = 0.286) as well as Qmax (15.9, 15.9, and 14.2 mL/s; p = 0.690) and PVR (33.7, 28.4, and 14.2 mL; p = 0.395) were not significantly different among the groups. Conclusion: Although a larger prostate requires more time and energy delivery, photoselective laser vaporization of the prostate is safe and efficacious for patients with LUTS regardless of prostate volume.

참고문헌 (Reference)

1 Barber NJ, "Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate" 67 : 80-83, 2006

2 Monoski MA, "Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention" 68 : 312-317, 2006

3 Spaliviero M, "Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)" 22 : 2341-2347, 2008

4 Volkan T, "Short term outcomes of high power (80 W) potassium-titanylphosphate laser vaporization of the prostate" 48 : 608-613, 2005

5 Kuntzman RS, "Potassiumtitanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines" 48 : 575-583, 1996

6 Hai MA, "Photoselective vaporization of the prostate:initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia" 17 : 93-96, 2003

7 Bachmann A, "Photoselective vaporization of the prostate: the basel experience after 108 procedures" 47 : 798-804, 2005

8 Kumar SM, "Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate" 173 : 511-513, 2005

9 Lee R, "Photoselective vaporization of the prostate using a laser high performance system in the canine model" 180 : 1551-1553, 2008

10 Te AE, "Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial" 72 : 1404-1408, 2004

11 Sarica K, "Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients" 19 : 1199-1202, 2005

12 Bachmann A, "Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome" 48 : 965-971, 2005

13 Malek RS, "Photoselective potassiumtitanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes" 174 : 1344-1348, 2005

14 Sandhu JS, "Photoselective laser vaporization prostatectomy in men receiving anticoagulants" 19 : 1196-1198, 2005

15 Sulser T, "Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures" 18 : 976-981, 2004

16 Bouchier-Hayes DM, "KTP laser versus transurethral resection: early results of a randomized trial" 20 : 580-585, 2006

17 Paick JS, "Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study" 4 : 1701-1707, 2007

18 Te AE, "Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy:analysis and results of an ongoing prospective multicentre study at 3 years" 97 : 1229-1233, 2006

19 Du C, "Holmium laser enucleation of the prostate: the safety, efficacy, and learning experience in China" 22 : 1031-1036, 2008

20 Krambeck AE, "Holmium laser enucleation of the prostate for prostates larger than 175 grams" 24 : 433-437, 2010

21 Kuntzman RS, "Highpower (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers" 49 : 703-708, 1997

22 Sandhu JS, "High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates" 64 : 1155-1159, 2004

23 Reich O, "High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients" 173 : 158-160, 2005

24 Reich O, "Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate" 171 : 2502-2504, 2004

25 Fu WJ, "Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia" 8 : 367-371, 2006

26 Rieken M, "Complications of laser prostatectomy: a review of recent data" 28 : 53-62, 2010

27 Naspro R, "A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporization and holmium laser enucleation of the prostate" 55 : 1345-1357, 2009

28 Shingleton WB, "A randomized prospective study of transurethral electrovaporization vs. laser ablation of the prostate in men with benign prostatic hypertrophy" 32 : 266-269, 1998

29 Shingleton WB, "A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia" 54 : 1017-1021, 1999